The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125464231 12546423 1 I 20160630 20160711 20160711 EXP GR-ELI_LILLY_AND_COMPANY-GR201607000375 ELI LILLY AND CO 0.00 F Y 0.00000 20160707 CN GR GR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125464231 12546423 1 PS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Unknown UNK, UNKNOWN U U 20509
125464231 12546423 2 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 U U 20509
125464231 12546423 3 SS CARBOPLATIN. CARBOPLATIN 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 4 SS DOCETAXEL. DOCETAXEL 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 5 SS EPIRUBICIN EPIRUBICIN 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 6 SS TAMOXIFEN TAMOXIFEN 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 7 SS PACLITAXEL. PACLITAXEL 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 8 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 9 SS ANASTROZOLE. ANASTROZOLE 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 10 SS NAVELBINE VINORELBINE TARTRATE 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 11 SS FASLODEX FULVESTRANT 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 12 SS BEVACIZUMAB BEVACIZUMAB 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 13 SS CAPECITABINE. CAPECITABINE 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 14 SS LIPOSOMAL DOXORUBICIN HCL DOXORUBICIN HYDROCHLORIDE 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 15 SS AFINITOR EVEROLIMUS 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 16 SS ABRAXANE PACLITAXEL 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 17 SS ERIBULIN ERIBULIN 1 Unknown UNK, UNKNOWN U U 0
125464231 12546423 18 SS EXEMESTANE. EXEMESTANE 1 Unknown UNK, UNKNOWN U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125464231 12546423 1 Breast cancer metastatic
125464231 12546423 2 Neoplasm recurrence
125464231 12546423 3 Breast cancer metastatic
125464231 12546423 4 Breast cancer metastatic
125464231 12546423 5 Breast cancer metastatic
125464231 12546423 6 Breast cancer metastatic
125464231 12546423 7 Breast cancer metastatic
125464231 12546423 8 Breast cancer metastatic
125464231 12546423 9 Breast cancer metastatic
125464231 12546423 10 Breast cancer metastatic
125464231 12546423 11 Breast cancer metastatic
125464231 12546423 12 Breast cancer metastatic
125464231 12546423 13 Breast cancer metastatic
125464231 12546423 14 Breast cancer metastatic
125464231 12546423 15 Breast cancer metastatic
125464231 12546423 16 Breast cancer metastatic
125464231 12546423 17 Breast cancer metastatic
125464231 12546423 18 Breast cancer metastatic

Outcome of event

Event ID CASEID OUTC COD
125464231 12546423 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125464231 12546423 Acute lymphocytic leukaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found